LifeStance Therapists & Psychiatrists Champaign
2506 Galen Drive, Suite 101, Champaign
4.6(45 Google reviews)
United States
7 listed treatment centers serving Champaign and the surrounding area.
2506 Galen Drive, Suite 101, Champaign
4.6(45 Google reviews)
201 West Springfield Avenue, Suite 909, Champaign
5.0(8 Google reviews)
For people in Champaign, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for supervised dosing and monitoring may generate charges. Ask for a written estimate that explains these components rather than assuming one quoted charge includes everything.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you tried and your response. Ask the treatment center who gathers those records, who submits the authorization request, and whether approval is needed before scheduling. Authorization does not necessarily mean you will have no out-of-pocket costs.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Illinois Medicaid coverage also depends on the applicable program and plan requirements. The Champaign listings do not identify any centers as accepting Medicare or Medicaid; confirm directly rather than treating a directory listing as proof of participation.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Ask about current eligibility rules and which charges a program may help with; do not assume it covers monitoring visits.
Before starting Spravato, ask the center and insurer:
SPRAVATO® treatment takes place only in a REMS-certified healthcare setting. You self-administer the nasal spray under direct observation; it is never sent home for use. This directory lists seven Champaign centers offering Spravato, but their REMS certification status is not recorded. Confirm current certification and appointment availability directly before making plans.
Plan for at least two hours of monitoring after each dose, plus any time needed for check-in, assessment, and dosing. Your total visit may be longer, and the care team decides when you are ready to leave. For treatment-resistant depression, the typical labeled schedule begins twice weekly during weeks 1–4, then weekly during weeks 5–8, with weekly or every-other-week maintenance afterward. Your prescriber will individualize the schedule; do not assume a fixed long-term frequency.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and pickup requirements before relying on a taxi or rideshare. A backup ride can help if your usual driver becomes unavailable.
When arranging time off work, account for the full appointment, travel, and restrictions afterward—especially if your work involves driving or machinery. Discuss scheduling needs with the center early.
If no Champaign center is listed when you search, or local appointments are unavailable, other Illinois cities with listings include Bloomington, Peoria, Chicago, Rockford, Aurora, Orland Park, Naperville, and Waukegan. These are search options, not confirmed referral destinations. Verify certification, insurance participation, availability, and a workable ride plan before booking.
This directory lists seven Champaign centers offering Spravato, but their REMS certification status is not recorded. Contact a center and ask whether the specific treatment location is currently REMS-certified, accepting new patients, and able to work with your insurance. A listing alone does not confirm certification, coverage, or appointment availability.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your diagnosis, treatment history, and safety considerations before deciding whether it is appropriate.
Coverage depends on your plan and the treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements. Ask your insurer about both medication and monitoring-visit benefits, and confirm network status with the center. Medicare and Illinois Medicaid may cover treatment in some circumstances, but the Champaign listings do not identify centers as accepting either.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. After dosing, staff monitor you for at least two hours for effects such as sedation, dissociation, breathing problems, and blood pressure increases. Allow extra time for assessment and dosing. You need someone else to take you home and cannot drive until the next day after restful sleep.
Ask about sedation, dissociation—feeling detached from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Share your medical history and medication list so the clinician can assess risks and explain monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911. Do not wait for a treatment consultation or insurance approval to seek urgent help.
Approved uses, nearby treatment centers, and medically sourced patient guides.